CHI3L1 and systemic sclerosis: However, we have provided unambiguous evidence illustrating the aberrant expression of Chi3L1 in the basal cells of patients with SSc, as well as the pro‐fibrotic role and mechanism of Chi3L1 in SSc, which holds significant clinical relevance.